Richard G Wunderink

  • 18933 Citations
1984 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My research interests revolve around understanding the risk factors, including host genetic risk, and improving outcomes of critically ill patients with serious infections. This includes severe community-acquired pneumonia, sepsis of all causes, and nosocomial infections, particularly ventilator-associated pneumonia.

Certifications and Licenses

Internal Medicine
Critical Care Medicine
Pulmonary Disease

Training Experience

1983Residency, Butterworth Hospital
1985Fellowship, Henry Ford Hospital

Education/Academic qualification

MD, Indiana University

… → 1980

Research interests

  • Critical Care
  • Critical Care Outcomes
  • Genetics: Medical
  • Pneumonia

Fingerprint Dive into the research topics where Richard G Wunderink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles
Pneumonia Medicine & Life Sciences
Ventilator-Associated Pneumonia Medicine & Life Sciences
Anti-Bacterial Agents Medicine & Life Sciences
Linezolid Medicine & Life Sciences
Bacterial Pneumonia Medicine & Life Sciences
Artificial Respiration Medicine & Life Sciences
Methicillin-Resistant Staphylococcus aureus Medicine & Life Sciences
Intensive Care Units Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2024

Systems Analysis
Patient Care
Neoplasms
Intensive Care Units
Quality of Life
training program
trainee
science
biology
career

Research Output 1984 2019

8 Citations (Scopus)

A global priority list of the TOp TEn resistant Microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis

Rello, J., Kalwaje Eshwara, V., Lagunes, L., Alves, J., Wunderink, R. G., Conway-Morris, A., Rojas, J. N., Alp, E. & Zhang, Z., Feb 4 2019, In : European Journal of Clinical Microbiology and Infectious Diseases. 38, 2, p. 319-323 5 p.

Research output: Contribution to journalArticle

Carbapenems
Decision Support Techniques
Critical Care
Intensive Care Units
beta-Lactamases
4 Citations (Scopus)

An international perspective on hospitalized patients with viral community-acquired pneumonia

the GLIMP Study Group, Feb 2019, In : European Journal of Internal Medicine. 60, p. 54-70 17 p.

Research output: Contribution to journalArticle

Internationality
Pneumonia
Oseltamivir
Viruses
Orthomyxoviridae
3 Citations (Scopus)

A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands

Gessner, B. D., Jiang, Q., Van Werkhoven, C. H., Sings, H. L., Webber, C., Scott, D., Neuzil, K. M., O'Brien, K. L., Wunderink, R. G., Grobbee, D. E., Bonten, M. J. M. & Jodar, L., Sep 10 2019, In : Vaccine. 37, 38, p. 5777-5787 11 p.

Research output: Contribution to journalArticle

Conjugate Vaccines
randomized clinical trials
Netherlands
public health
Randomized Controlled Trials

A quantitative approach for the analysis of clinician recognition of acute respiratory distress syndrome using electronic health record data

Bechel, M. A., Pah, A. R., Shi, H., Mehrotra, S., Persell, S. D., Weiner, S., Wunderink, R. G., Nunes Amaral, L. A. & Weiss, C. H., Jan 1 2019, In : PloS one. 14, 9, e0222826.

Research output: Contribution to journalArticle

Open Access
Electronic Health Records
Adult Respiratory Distress Syndrome
electronics
physicians
Health
6 Citations (Scopus)

Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial

Kollef, M. H., Nováček, M., Kivistik, Ü., Réa-Neto, Á., Shime, N., Martin-Loeches, I., Timsit, J. F., Wunderink, R. G., Bruno, C. J., Huntington, J. A., Lin, G., Yu, B., Butterton, J. R. & Rhee, E. G., Dec 2019, In : The Lancet Infectious Diseases. 19, 12, p. 1299-1311 13 p.

Research output: Contribution to journalArticle

meropenem
Pneumonia
Therapeutics
Ventilator-Associated Pneumonia
Mortality